Dr. Christine Chung, MD
Claim this profileMoffitt Cancer Center
Studies Squamous Cell Carcinoma
Studies Head and Neck Squamous Cell Carcinoma
15 reported clinical trials
30 drugs studied
Area of expertise
1Squamous Cell Carcinoma
Stage IV
p16 positive
p16 negative
2Head And Neck Squamous Cell Carcinoma
Stage IV
HPV positive
Stage III
Affiliated Hospitals
Clinical Trials Christine Chung, MD is currently running
Cemiplimab + Cetuximab
for Head and Neck Cancer
The purpose of the study is to determine if cemiplimab in combination with cetuximab given before their surgery are beneficial and safe in participants with head and neck squamous cell carcinoma (HNSCC).
Recruiting1 award Phase 23 criteria
ACR-368 + Gemcitabine
for Head and Neck Cancer
The purpose of the study is to determine the activity and safety of ACR-368 (prexasertib) in combination with gemcitabine in participants with Head and Neck Squamous Cell Carcinoma (HNSCC). Participants will receive the study drugs ACR-368 and a low dose of gemcitabine once every 2 weeks in 4-week cycles and will continue on treatment unless the disease deteriorates.
Recruiting1 award Phase 210 criteria
More about Christine Chung, MD
Clinical Trial Related1 year of experience running clinical trials · Led 15 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments Christine Chung, MD has experience with
- Cemiplimab
- Intensity-Modulated Radiation Therapy
- Cisplatin
- Pembrolizumab
- ACR-368
- Gemcitabine
Breakdown of trials Christine Chung, MD has run
Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma
Head and Neck Cancers
Throat Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Christine Chung, MD specialize in?
Christine Chung, MD focuses on Squamous Cell Carcinoma and Head and Neck Squamous Cell Carcinoma. In particular, much of their work with Squamous Cell Carcinoma has involved Stage IV patients, or patients who are p16 positive.
Is Christine Chung, MD currently recruiting for clinical trials?
Yes, Christine Chung, MD is currently recruiting for 7 clinical trials in Tampa Florida. If you're interested in participating, you should apply.
Are there any treatments that Christine Chung, MD has studied deeply?
Yes, Christine Chung, MD has studied treatments such as Cemiplimab, Intensity-Modulated Radiation Therapy, Cisplatin.
What is the best way to schedule an appointment with Christine Chung, MD?
Apply for one of the trials that Christine Chung, MD is conducting.
What is the office address of Christine Chung, MD?
The office of Christine Chung, MD is located at: Moffitt Cancer Center, Tampa, Florida 33612 United States. This is the address for their practice at the Moffitt Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.